Scotland · NHS Scotland MSAN
PROVERA® (MEDROXYPROGESTERONE ACETATE) 100mg AND 200mg
MSAN(2019)16 · Level 21 · issued 15 Nov 2019
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Provera® 400mg tablets are available but cannot support an increase in demand. | Available — cannot support uplift | — |
| 2. Unlicensed imports of medroxyprogesterone 100mg tablets remain available. | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.